I Want My DNA!

Writing in the New Scientist, Daniel MacArthur and Caroline Wright say that when it comes to DTC genetic testing, they "believe that regulation is needed, but are worried that it will focus too heavily on 'protecting' consumers from their own genomes." The authors note that once "lauded" as Time's invention of the year, personal genome scans have had a hard time "living up to that promise," and consequently their medical value has been limited. But, MacArthur and Wright say, not all DTC companies hold themselves to the same standards.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.